[...] – Q1 2014 Merck Group | Business free cash flow by division – Q1 2014 Merck Group | Number of employees as of March 31, 2014: 38,273 As of March 31, 2014, Merck had 38,273 employees wordwide compared to 38,154 on December 31, 2013.
Merck conducts research and development worldwide in order to develop new products and services designed to improve the quality of life of patients and customers. Also in the first quarter of 2014, we focused on further optimizing the relevance and profitability of our research and development activities and we increased the number of new collaborations with external research and development partners. Nearly 4,000 employees around the world work for Merck researching innovations to serve long-term health and technology trends in established and emerging markets as well as in developing countries. Overall, the Merck Group invested around € 379 million in research [...]
[...] to 97.9%. Merck will quickly being with the integration of AZ and its workforce of approximately 1,150 employees worldwide. All important integration activities are to be completed by the end of 2014. With annual sales of around US$ 730 million in 2013, AZ is a leading supplier of high-tech materials with a production focus in Asia, where the company achieves nearly 80% of its sales. AZ generates more than 80% of its sales with products that are the leaders in their respective markets. Products from AZ are essential components of integrated circuits, flat-panel displays and light-emitting diodes. AZ is thus a key partner to leading global manufacturers of [...]
[...] the time value of Merck Share Units (MSUs). MSUs are virtual Merck shares that eligible executives and employees could receive at the end of a three-year performance period within the scope of the Merck Long-Term Incentive Plan. Income tax expenses of € 106 million (Q1 2013: € 72 million) led to a tax ratio of 24.5% (Q1 2013: 21.0%). Owing to the development of expenses and income, net income attributable to Merck shareholders increased by 22.2% to € 325 million (Q1 2013: € 266 million), leading to earnings per share of € 1.50 (Q1 2013: € 1.22). XLS Merck Group | Reconciliation of EBIT to EBITDA pre one-time items € million Q1 – 2014 Q1 – 2013 [...]
[...] silicon-chemistry-based products for optoelectronics. As of the end of 2013, AZ had a total of 1,131 employees. AZ will be integrated into the Performance Materials division. The aim of the acquisition is to further strengthen Merck’s materials and specialty chemicals business by joining forces with one the leading suppliers of high-tech materials for the electronics industry. Since legal regulations prevented Merck from accessing information needed to perform the purchase price allocation before the date on which it obtains control of AZ, the disclosure of further information – for instance on the fair values of the acquired assets and liabilities – was not [...]
